🇺🇸 alverine citrate, simeticone in United States

42 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Loss Of Consciousness — 7 reports (16.67%)
  2. Beta Haemolytic Streptococcal Infection — 6 reports (14.29%)
  3. Necrosis Ischaemic — 6 reports (14.29%)
  4. Pneumonia Streptococcal — 6 reports (14.29%)
  5. Septic Shock — 6 reports (14.29%)
  6. Confusional State — 3 reports (7.14%)
  7. Aggression — 2 reports (4.76%)
  8. Agitation — 2 reports (4.76%)
  9. Headache — 2 reports (4.76%)
  10. Hypotension — 2 reports (4.76%)

Source database →

alverine citrate, simeticone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is alverine citrate, simeticone approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for alverine citrate, simeticone in United States?

Laboratoires Mayoly Spindler is the originator. The local marketing authorisation holder may differ — check the official source linked above.